Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | tert-Butyl(2-iodoethoxy)dimethylsilane | HCID 11129873 | — |
| Reactant | 1-t-butoxycarbonyl-4-(1H-benzimidazol-2-yl)[1,4]diazepane | HCID 18464655 | — |
| Reactant | Dichloromethane ethylacetate | HCID 21226138 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 18464522 | HCID 18464522 | — |
Reaction Steps
Alternately, combine 1-(t-butoxycarbonyl)-4-(1H-benzimidazol-2-yl)[1,4]diazepane (1.72 g, 5.43 mmol) and sodium hydride (0.36 g, 60% in oil, 8.15 mmol) in dimethylformamide (40 mL). After 4 hours, add 2-(t-butyldimethylsilyloxy)ethyl iodide (1.56 g, 5.43 mmol). After 72 hours, heat to 80° C. After 3 hours, cool to ambient temperature and add ice to quench. Partition the reaction mixture between ethyl acetate (250 mL) and a saturated aqueous solution of sodium bicarbonate (200 mL). Separate the layers and extract the organic layer with water. Dry the organic layer over MgSO4, filter, and evaporate in vacuo to give a residue. Chromatograph the residue on silica gel eluting with 40% ethyl acetate/dichloromethane to give 1-(t-butoxycarbonyl)-4-(1-(2-(t-butyldimethylsilyloxy)ethyl)-1H-benzimidazol-2-yl)[1,4]diazepane.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06423704B1 |
|---|
| Source dataset | uspto-grants-2002_07 |
|---|
| ORD ID | ord-0cc9941b78264c74bc572d0cbf45b3d4 |
|---|
| Source note | uspto-grants-2002_07 |
|---|